"On April 4, the heads of the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) sent a letter to members of Congress that said a decision would likely be made on rescheduling "in the first half of 2016." With just three days left in June, that deadline is fast approaching"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.